Georges Naasan, MD


Dr. Georges Naasan is a neurologist who cares for patients with cognitive and behavioral disorders. His focus is neurodegenerative illnesses with dementia. He also provides remote second opinions for patients with various cognitive and behavioral disorders through the UCSF Online Remote Second Opinion Program. He is director of clinical services at the Memory and Aging Center.

As a researcher, Naasan studies hallucinations, delusions and other disturbances in perception arising from neurodegenerative diseases. He also investigates the relationship between neurological conditions and criminal behaviors in older adults.

Naasan earned his medical degree from the American University of Beirut. He completed a residency in neurology at Case Western Reserve University and fellowships in behavioral neurology and neuropsychiatry at UCSF.

Naasan is deeply committed to mentoring health care providers of any discipline who are interested in applying behavioral neurology and neuropsychiatry to their work with patients. He mentors medical students, residents, fellows and international scholars. He is also a faculty member of the Global Brain Health Institute, a partnership between UCSF and Trinity College in Dublin that trains and supports dementia experts on bringing research findings into policy and practice.

Naasan is a member of the American Academy of Neurology. He is an assistant professor of neurology at UCSF.


Memory and Aging Center
1500 Owens St., Suite 320
San Francisco, CA 94158
Phone: (415) 353-2057
Fax: (415) 353-8292

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Neurology, American Board of Psychiatry and Neurology

Academic Title

Assistant Professor

More about Georges Naasan

Additional Languages



American University of Beirut 2006


Case Western Reserve University, Neurology 2011


UCSF, Behavioral Neurology and Neuropsychiatry 2013

Selected Research and Publications

  1. Karageorgiou E, Naasan G, Pleasure SJ, Alexandrescu S, Gelfand JM, Tammewar G, Miller BL, Rabinovici GD, Grinberg LT. Focal cerebral -amyloid angiopathy: A distinct clinicopathologic presentation. Neurol Clin Pract. 2017 Oct; 7(5):444-448.
  2. Possin KL, Merrilees J, Bonasera SJ, Bernstein A, Chiong W, Lee K, Wilson L, Hooper SM, Dulaney S, Braley T, Laohavanich S, Feuer JE, Clark AM, Schaffer MW, Schenk AK, Heunis J, Ong P, Cook KM, Bowhay AD, Gearhart R, Chodos A, Naasan G, Bindman AB, Dohan D, Ritchie C, Miller BL. Development of an adaptive, personalized, and scalable dementia care program: Early findings from the Care Ecosystem. PLoS Med. 2017 Mar; 14(3):e1002260.
  3. Naasan G, Rabinovici GD, Ghosh P, Elofson JD, Miller BL, Coppola G, Karydas A, Fong J, Perry D, Lee SE, Yokoyama JS, Seeley WW, Kramer JH, Weiner MW, Schuff N, Jagust WJ, Grinberg LT, Pribadi M, Yang Z, Sears R, Klein E, Wojta K, Rosen HJ. Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase. 2016; 22(1):76-83.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.